Search

everythinglearnresearchcommunity

for

Search:↓

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Ziziphus jujuba and Eclipta alba leaf extracts improve blood sugar levels and cognitive function in diabetic rats.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Pranlukast and mirabegron may work as new diabetes drugs.

A medicine company has recalled a drug because it contained an unlisted blood pressure medication.

A woman's temporary hair loss was caused by high prolactin levels from her medication.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Finasteride may worsen blood sugar control in diabetic patients.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

GLP-1 agonists may increase the risk of hair loss.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

GLP-1RA therapy may increase the risk of hair loss.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Divalproex sodium can sometimes worsen behavior in some patients.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Troglitazone increases subcutaneous fat in lipodystrophy patients.